Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban for VTE in Cancer Patients
NCT03045406Phase 3Completed
- Sponsor
- Fondazione FADOI
- Start
- Apr 2017
- Primary completion
- Jun 2019
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of apixaban in venous thromboembolism (VTE), sponsored by Fondazione FADOI. Started Apr 2017; status: completed.
02
Drugs
apixaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT03045406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03045406.